Australia markets closed

Immunovant, Inc. (IMVT)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
27.17-0.58 (-2.09%)
At close: 04:00PM EDT
27.17 0.00 (0.00%)
After hours: 05:27PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/03/2023
31/03/2022
31/03/2021
Cash flows from operating activities
Net income
-243,449
-210,960
-156,730
-107,431
Depreciation & amortisation
221
193
126
65
Stock-based compensation
38,983
32,296
34,244
18,822
Change in working capital
-7,241
-10,853
15,142
4,566
Accounts receivable
-435
11,764
-11,633
-596
Accounts payable
-10,237
-17,124
16,254
1,251
Other working capital
-210,557
-188,390
-106,366
-83,537
Other non-cash items
1,165
1,131
1,106
651
Net cash provided by operating activities
-210,321
-188,193
-106,112
-83,327
Cash flows from investing activities
Investments in property, plant and equipment
-236
-197
-254
-210
Net cash used for investing activities
-236
-197
-254
-210
Cash flows from financing activities
Debt repayment
-
-
0
-3,190
Common stock issued
472,745
70,500
0
319,783
Other financing activities
-6,012
-272
200,129
-140
Net cash used provided by (used for) financing activities
471,115
70,885
200,129
383,112
Net change in cash
258,329
-117,285
93,671
299,575
Cash at beginning of period
432,608
493,817
400,146
100,571
Cash at end of period
693,166
376,532
493,817
400,146
Free cash flow
Operating cash flow
-210,321
-188,193
-106,112
-83,327
Capital expenditure
-236
-197
-254
-210
Free cash flow
-210,557
-188,390
-106,366
-83,537